Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|February 26, 1998
High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemiaI Woolley, D Curtis, J Szer, et al.
Internal Medicine Journal|March 2, 2005
Enzyme replacement therapy for Gaucher disease in AustraliaJ Goldblatt, J Szer, J M Fletcher, et al.
Leukemia & Lymphoma|September 1, 1994
Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patientsJ D Lickliter, C G Begley, A W Boyd, et al.
Bone Marrow Transplantation|August 11, 2001
Acute left ventricular failure following melphalan and fludarabine conditioningD S Ritchie, J F Seymour, A W Roberts, et al.
Australian and New Zealand Journal of Medicine|March 4, 1998
Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantationD M Thomas, J F Seymour, J D Griffiths, et al.
Bone Marrow Transplantation|January 17, 2012
Constrictive pericarditis and primary effusion lymphoma following allogeneic BMT for CMLH Rose, M Kulik, R Standish, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 4, 2007
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipientS Y C Tong, A Y Peleg, J Yoong, et al.
Transfusion Medicine (Oxford, England)|March 1, 1992
The definition of refractoriness to platelet transfusionsJ F Bishop, J P Matthews, K Yuen, et al.
Human Immunology|July 1, 1997
Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid differenceI Nicholson, M Varney, C Kanaan, et al.
Leukemia Research|January 1, 1997
Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cellsR L Sparrow, E O'Flaherty, T M Blanksby, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|February 26, 1998
High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemiaI Woolley, D Curtis, J Szer, et al.
Internal Medicine Journal|March 2, 2005
Enzyme replacement therapy for Gaucher disease in AustraliaJ Goldblatt, J Szer, J M Fletcher, et al.
Leukemia & Lymphoma|September 1, 1994
Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patientsJ D Lickliter, C G Begley, A W Boyd, et al.
Bone Marrow Transplantation|August 11, 2001
Acute left ventricular failure following melphalan and fludarabine conditioningD S Ritchie, J F Seymour, A W Roberts, et al.
Australian and New Zealand Journal of Medicine|March 4, 1998
Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantationD M Thomas, J F Seymour, J D Griffiths, et al.
Bone Marrow Transplantation|January 17, 2012
Constrictive pericarditis and primary effusion lymphoma following allogeneic BMT for CMLH Rose, M Kulik, R Standish, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 4, 2007
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipientS Y C Tong, A Y Peleg, J Yoong, et al.
Transfusion Medicine (Oxford, England)|March 1, 1992
The definition of refractoriness to platelet transfusionsJ F Bishop, J P Matthews, K Yuen, et al.
Human Immunology|July 1, 1997
Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid differenceI Nicholson, M Varney, C Kanaan, et al.
Leukemia Research|January 1, 1997
Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cellsR L Sparrow, E O'Flaherty, T M Blanksby, et al.
Pageof 20